The potential of B cells to serve a mechanistic role in this disease is shown by a retrospective study in which stable outpatients with end stage ILD who received CD20 targeted therapy (which removes B cells) showed a trend toward improved lung function ( 169 ).
← all excerpts
The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis.
1
—
—